Warby Parker (WRBY) Earnings Analysis
Warby Parker (WRBY) has no confirmed upcoming earnings date. Last quarter (2026-05-07) it beat with EPS 0.12 USD vs 0.11 USD est (+9.1%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E 2134.78.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does WRBY next report earnings?
No confirmed upcoming earnings date is currently scheduled for WRBY. This page updates as the calendar is published.
WRBY earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | 0.12 USD | 0.11 USD | +9.1% | Beat |
| 2026-02-26 | -0.04 USD | 0.05 USD | -180% | Miss |
| 2025-11-06 | 0.11 USD | 0.09 USD | +22.2% | Beat |
| 2025-08-07 | 0.08 USD | 0.08 USD | 0% | Beat |
| 2025-02-27 | 0.01 USD | 0.03 USD | -66.7% | Miss |
| 2024-11-07 | 0.05 USD | 0.05 USD | 0% | Beat |
Beat rate: 4/6 (67%) over reported quarters with consensus data.
WRBY valuation and analyst view
| Trailing P/E | 2134.78 |
|---|---|
| Trailing EPS | 0.0109 USD |
| Price / book | 8.06 |
| Dividend yield | 0.00% |
| Market cap | 3.01B |
| Analyst consensus | Buy (8 buy / 7 hold / 0 sell) |
| Avg price target | 31 USD |
Related research pages
Frequently asked questions
When is Warby Parker (WRBY)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for WRBY. This page updates as the calendar is published.
Did WRBY beat earnings last quarter?
In its 2026-05-07 report, WRBY posted EPS of 0.12 USD versus a 0.11 USD estimate — a beat of 9.1%.
What is WRBY's earnings track record?
Over the last 6 reported quarters with consensus data, WRBY beat estimates 4 times (67%).
What is WRBY's current P/E ratio and EPS?
WRBY trades at a trailing P/E of 2134.78 on trailing EPS of 0.01090425962831543 USD.
What do analysts rate WRBY?
Analyst consensus is "Buy" across 15 ratings (0 strong buy, 8 buy, 7 hold, 0 sell, 0 strong sell). Average 12-month price target: 31 USD.